Corient Capital Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $6.53M | Hold |
|
|||||
|
2022
Q2 | $6.53M | Buy |
|
|||||
|
2022
Q1 | $5.85M | Buy |
|
|||||
|
2021
Q4 | $4.55M | Buy |
|
|||||
|
2021
Q3 | $3.95M | Sell |
|
|||||
|
2021
Q2 | $4.47M | Sell |
|
|||||
|
2021
Q1 | $4.25M | Sell |
|
|||||
|
2020
Q4 | $4.18M | Buy |
|
|||||
|
2020
Q3 | $3.97M | Buy |
|
|||||
|
2020
Q2 | $3.72M | Buy |
|
|||||
|
2020
Q1 | $3.41M | Buy |
|
|||||
|
2019
Q4 | $3.58M | Buy |
|
|||||
|
2019
Q3 | $1.05M | Buy |
|
|||||
|
2019
Q2 | $540K | Buy |
|
|||||
|
2019
Q1 | $431K | Buy |
|
|||||
|
2018
Q4 | $462K | Buy |
|
|||||
|
2018
Q3 | $345K | Hold |
|
|||||
|
2018
Q2 | $307K | Buy |
|
|||||
|
2018
Q1 | $233K | Sell |
|
|||||
|
2017
Q4 | $253K | Sell |
|
|||||
|
2017
Q3 | $279K | Sell |
|
|||||
|
2017
Q2 | $281K | Sell |
|
|||||
|
2017
Q1 | $279K | Sell |
|
|||||
|
2016
Q4 | $337K | Sell |
|
|||||
|
2016
Q3 | $318K | Buy |
|